Special Products becomes Veriton Pharma

Special Products becomes Veriton Pharma

October 3 2017 Special Products Ltd has changed its name to Veriton Pharma Limited, to better...

Quantum Pharmaceutical introduces new ordering system for Specials

Quantum Pharmaceutical introduces new ordering system for Specials

August 18 2017 Quantum Pharmaceutical is updating its ordering system for Specials medicines to...

Updated guidance for prescribing specials medicines published

Updated guidance for prescribing specials medicines published

June 15 2016 The Royal Pharmaceutical Society has published new guidance on prescribing specials...

Drug alert issued for Epistatus Oromucosal Solution 10mg/ml

Drug alert issued for Epistatus Oromucosal Solution 10mg/ml

May 31 2016 A drug recall for a batch of the specials product Epistatus (midazolam maleate)...

Drug Tariff updates include specials and unlicensed medicines price amendments

Drug Tariff updates include specials and unlicensed medicines price amendments

February 1 2016 The latest list of prices for specials and unlicensed medicines has been...

  • Special Products becomes Veriton Pharma

    Special Products becomes Veriton Pharma

    Tuesday, 03 October 2017 18:03
  • Quantum Pharmaceutical introduces new ordering system for Specials

    Quantum Pharmaceutical introduces new ordering system for Specials

    Friday, 18 August 2017 15:27
  • Updated guidance for prescribing specials medicines published

    Updated guidance for prescribing specials medicines published

    Wednesday, 15 June 2016 14:54
  • Drug alert issued for Epistatus Oromucosal Solution 10mg/ml

    Drug alert issued for Epistatus Oromucosal Solution 10mg/ml

    Sunday, 05 June 2016 22:37
  • Drug Tariff updates include specials and unlicensed medicines price amendments

    Drug Tariff updates include specials and unlicensed medicines price amendments

    Monday, 01 February 2016 12:29

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

Drug TariffNovember 2 2015

The Drug Tariff listings of specials and unlicensed products listed has been updated for November.

In Scotland, there have been two Specials Tariff Part 7S deletions, taking the total number of products listed to 75, says unlicensed medicines manufacturer Quantum Pharmaceutical. The next update of specials in Scotland is expected in the February 2016 Drug Tariff.

In England and Wales, 13 new additions and six deletions have been made to Part VIIIB of the Drug Tariff, says Quantum. This brings the list to 249 items.

PSNC has flagged up that there has been a change to the way chloral hydrate is listed to reflect BP nomenclature: chloral hydrate 500mg/5ml oral solution has replaced Chloral Hydrate 500mg/5ml Mixture BP.

In addition, PSNC has advised that lisinopril 2.5mg/5ml oral solution and suspension and lisinopril 5mg/5ml oral solution and suspension have been deleted from Part VIIIB because a licensed alternative, lisinopril 5mg/5ml oral solution sugar-free, has been added to Part VIIIA.

“Pharmacy staff are advised to take care in ensuring that any prescriptions dispensed in October are submitted promptly for payment with their October prescription bundle, to avoid the risk of items being reimbursed at the November Drug Tariff price, which may vary from those charged in October,” it advises.

Links:

Quantum Pharmaceutical statement

PSNC statement

Specials News

November 22 2017 The public and health professionals are being asked to consider reporting side effects from over the counter medicines via the Yellow Card scheme.
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...